Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Nanopore Expands Agreement with University of Oxford


Oxford Nanopore Technologies said this week that it has signed a new agreement with the University of Oxford that will further strengthen its ties with its scientific co-founder, Hagan Bayley, a professor at Oxford.

Under the new agreement, which has an undisclosed duration, the company will provide an undisclosed amount of funding to support research in Bayley's group and will partner exclusively with the university to develop "revolutionary products for molecular analysis" based on discoveries made by the group.

Research projects in Bayley's group include the development of methods for direct sequencing of single-stranded DNA. The team receives funding under the National Human Genome Research Institute's "$1,000 Genome" grant program (see other article, this week).

Oxford Nanopore has already collaborated with Bayley's group extensively under a previous agreement.

According to an Oxford Nanopore spokesperson, the new agreement differs from the old one in that it now includes a "broad range of nanopore sensing discoveries" from Bayley's laboratory. The previous agreement, she said, was structured around specific projects.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.